Regadenoson
- Product NDC
- 67457-994
- 11-digit product format
- 674570994
- Labeler code
- 67457
- Product ID
- 67457-994_e6bccf18-bc12-4f68-a021-af21b5026e16
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Regadenoson
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA213856
- Marketing category
- ANDA
- Marketing start
- 2023-09-21
- Marketing end
- 2026-06-30
- Substance
- REGADENOSON
- Active strength
- .4 mg/5mL
- Pharmacologic classes
- Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 2XLN4Y044H | REGADENOSON | 875148-45-1 | REGADENOSON |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-994-05 | 67457099405 | 1 SYRINGE in 1 CARTON (67457-994-05) / 5 mL in 1 SYRINGE | 1 syringe | 2023-09-21 | 2026-06-30 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Regadenoson | Mylan Institutional LLC | 2022-11-15 | HUMAN PRESCRIPTION DRUG LABEL | 3 |